Objective: The aim of this study was to evaluate the effect of C. zeylanicum aqueous extract on cell growth in the human myelocytic leukemia cell line (THP-1). Background: Today, application of Cinnamon for treatment of cancer investigates extensively. Cinnamon has antioxidant, anti-apoptotic and anti-infl ammatory properties. Methods: In this experimental study, THP-1 was incubated in 2, 1, 0.1 and 0.01 mg/ml C. zeylanicum solutions for 24, 48 and 72 hours. Cell cycle was assessed with fl ow cytometry. Apoptotic cells were identifi ed by Hoechst 33342 staining. Cell proliferation was assessed by the MTT assay. The data were analyzed using descriptive statistics and analytical tests. Results: Samples that supplemented with 0.1 mg/ml C. zeylanicum aqueous extract enhanced induction of apoptosis in THP-1 cell line compared to samples that supplemented with 2, 1 and 0.01 mg/ml. According to fl ow cytometry analysis, after 24 and 72 hours of incubation in 0.1 and 2 mg/ml C. zeylanicum aqueous extract, respectively, the amount of cells in apoptosis phase was higher than that in the control sample. Conclusion: Supplemented C. zeylanicum aqueous extract induced apoptosis in the human myelocytic leukemia cell line (Fig. 4, Ref. 20). Text in PDF www.elis.sk.
Introduction
Leukemia and Lymphoma, among the different types of cancer, have a high importance with Global Outbreak 3-5 percent (1) . Acute Myeloid Leukemia is hematopoietic cell neoplastic disorder caused by chromosomal abnormalities and mutations in blood precursor cells (2) . The ability of cells to respond to signals that stimulate the differentiation and maturation are lost. High proliferation of early hematopoietic cells in the bone marrow and loss of differentiation into mature cells lead to a large accumulation of malignant cells in the bone marrow and ultimate in blood (3) . Today, various therapies used to eliminate malignant cells in leukemia. Chemotherapy is a common method in the treatment of leukemia. Today, researcher investigated other types of treatment such as treatment with medicinal plant extracts due to severe side effects of chemotherapy (4) . In recent years, researchers considered treatment with medicinal plant extracts. One of the strategies for treatments of cancer is prevent DNA synthesis or mitosis by blocking the progression of cell cycle in cells of the preneoplastic and malignant. Pharmaceutical plants have lethal impact on malignant or mutants cells by stopping the growth and proliferation (5) .
Cinnamomum zeylanicum (C. zeylanicum) belongs to Lauraceae family and it grows in Srilanka. C. zeylanicum is an ancient medicinal plant. It has been mentioned in Chinese texts from 4000 years ago (6) . In Ayurvedic medicine, cinnamon is suggested for the treatment of digestive, respiratory and gynecological disorders (7) . It was reported that the cinnamon extracts could have antioxidant (8) and anti-infl ammatory (9) effects. In diabetes-induced rats, C. zeylanicum recuperated lipid parameters and decreased blood glucose (7) . Furthermore, chronic supplementation of cinnamon had improved the fasting glucose and lipid levels in diabetic patients (10). Also, it had been reported that cinnamon could affect the cell cycle. Researchers have shown that cinnamon induced loss of growth and apoptosis in cancer cell lines such as U937 and Jurkat, Cervical cancer SiHa and HL-60 (11) (12) (13) . The aim of this study was to evaluate the effect of C. zeylanicum aqueous extract on the human myelocytic leukemia, THP-1, cell lines.
Materials and methods
This experimental laboratory study was done in the cell culture laboratory of Razi Herbal Medicine Research Center at Lorestan University of Medical Sciences in Khorramabad. C. zeylanicum was confi rmed by a botanist from Agriculture and Jahad Organization.
The C. zeylanicum was ground completely and then it was uniformed by a homogenizer. Afterwards, it was soaked in the distilled water and the aqueous extract was collected. Two, 1, 0.1 and 0.01 mg/ml solutions were made at the RPMI 1640 medium . These solutions were sterilized by Millipore fi ltration ( pore size: 0.02). These solutions were kept in a refrigerator until the usage.
Human myelocytic leukemia cell line (THP-1) was prepared from Pasteur Institute of Iran. The cells were incubated at 37 °C in the incubator (Memmert, Germany) with 5 % CO 2 and 90 % humidity, in the T 25 fl asks (NUNC, Denmark) and in the R PMI 1640 m edium (Gibco, Germany) supplemented with 10 % fetal calf serum (FCS), 100 mg/ ml streptomycin and 100 U/ml penicillin (Cinnagen, Iran).
THP-1 cells were incubated in 2, 1, 0.1 and 0.01 mg/ml C . zeylanicum solutions for 24, 48 and 72 hours. T he medium was used without cells as blank and the medium with cells and without C . zeylanicum solutions as the control. cells were plated at 10 4 cells/well on 96-well plates. At 24, 48 and 72 hours after transfection, 20 ml of MTT (5 mg/ml) was added to each well; the samples were incubated for 4 hour at 37 °C and then subculture to the medium with 200 microliter acidic isopropanol. The absorbance of each well was determined at 570 nm. Survival percentage (%) was calculated relative to the control. The percentage of growth inhibition was calculated by this formula (14): 10 0
The ce ll cycle was assessed with fl ow cytometry (Partec, Germany). The cells were centrifuged at 800 g. Cells were washed with cold ph osphate buffered saline (PB S) and were fi xed by ethanol 70 %. Fo r the evaluation of the cell cycle phases, the cells were mixed with 1 mi crogram pr opidium iodide (i n 1 ml PBS) and 25 mg RNase A (in 1 ml PBS) for 30 minutes and then assessed by fl ow cytometry (11) .
Apoptotic cells were id entifi ed by Ho echst 33342 staining and the use of fl uorescence microscope. Two million THP-1 cells we re counted using neobar glasses and then were separated. They were incubated in 0.1 mg/ml of aqueous extract of C. zeylanicum for 24 hours, respectively. The vital cells were used as the control. Afterward, 25 mi croliter of treated cell suspension and the control sample were mixed with 1 microliter of Hoechst stain (10 microgram/ml). Then, 10 microliters of this mixture were infused on a clean glass and at least 200 cells were evaluated by fl uorescence microscope.
Statistical analysis
The data were analyzed using the SPSS software (V. 18), descriptive statistics, and analytical tests (ANOVA and Tu key tests). p < 0.05 were considered statistically signifi cant.
Results
I n the evaluation using th e reverse phase microscope, in the incubated cell in 0.1 mg/ml C. zeylanicum solution for 24 hours, the wrinkled cells were seen and the number of the cells was lower than that in the control sample (Fig. 1) .
Th e results of THP-1 cells incubation in 2, 1, 0.1 and 0.01 mg/ml C. zeylanicum solutions for 24, 48 and 72 hours by MTT assay are shown in Figure 2 . The difference between ce ll growth inhibition after 72 and 48 hours of incubation in 0.01 mg/ml C. zeylanicum solutions was not signifi cant (p > 0.05), but the difference between cell growth inhibition after 48 and 24 hours of incubation was signifi cant (p < 0.001). The difference between cell growth inhibition after 72 and 48 hours and between 48 and 24 hours of incubation in 0.1 mg/ml C. zeylanicum solutions was signifi cant (p < 0.001). The difference between cell growth inhibition after 72 and 48 hours of incubation in 1 mg/ml C. zeylanicum solutions was not signifi cant (p > 0.05), but the difference between cell growth inhibition after 48 and 24 hours of incubation was signifi cant (p < 0.001). The difference between cell growth inhibition after 72 and 48 hours of incubation in 2 mg/ml C. zeylanicum solutions was not signifi cant (p > 0.05), but the difference between cell growth inhibition after 48 and 24 hours of incubation was signifi cant (p < 0.001).
Th e results of fl ow cytometry analysis are shown in Figure 3 . In the control sample, 0.6 % of the cells were in sub-G1 phase. Also, after 24 hours of incubation in 0.1 mg/ml C. zeylanicum solution, 55.09 % of the cells were in sub-G1 phase. Based on fl ow cytometry analysis, the amount of cells in apoptosis phase after 24 hours of incubation in 0.1 mg/ml was more than the other groups of study.
Th e amount of cells in apoptosis phase detected by Hoechst 33342 staining and the use of fl uorescence microscope after 24 hours of incubation in 0.1 mg/ml C. zeylanicum solutions was higher than the other groups of study (Fig. 4) .
Discussion
C . zeylanicum is an ancient medicinal plant. The effects of C. zeylanicum are due to the effects of its co mponents. Gursale et al., evaluated the Cinnamomum zeylanicum Blume extracts by reversed-phase high performance liquid chromatographic method (15) . Gursale et al. reported that Cinnamaldehyde was the major component of Cinnamomum zeylanicum Blume (15) . Also, Unlu et al., evaluated the es sential oil of C. zeylanicum Blume bark by GC-MS (16). Unlu et al reported that (E)-cinnamaldehyde, benzaldehyde and (E)-cinnamyl acetate were the main components of the essential oil (16) . On the other hand, Ka et al stated that Cinnamaldehyde was a component of Cinnamomum cassia stem bark (17) .
Th e results of our study showed that C. zeylanicum aq ueous extract induced apoptosis in the human myelocytic leukemia cell lines. In our study, incubation in 0.1 mg/ml C. zeylanicum solution compared to 2, 1 and 0.01 mg/ml C. zeylanicum solutions had more effects on THP-1 cells. Also, in our study, according to fl ow cytometry analysis after 24 of incubation in 0.1 mg/ml C. zeylanicum solutions, the amount of cells in apoptotic phase was higher than in the control sample.
Our fi ndings are in according with Schoene et al's study (11). Schoene et al assessed the effect of ci nnamon water-soluble fraction on lymphoma and leukemic cell lines. Schoene et al. declared that cinnamon water-soluble fraction decreased cellular growth in a lymphoma and two leukemic cell lines. However, Schoene et al. reported that the block occurred in G2/M phase.
As mentioned above, Cinnamaldehyde is a component of some kind of cinnamon. Ka et al reported that Ci nnamaldehyde can induce the apoptosis (17) . Also, Ng and Wu assessed the antiproliferative activity of cinnamaldehyde, cinnamic acid and cinnamyl alcohol on human hepatoma Hep G2 cells. Ng and Wu reported that, compared with cinnamic acid and cinnamyl alcohol, cinnamaldehyde had more antiproliferative activity (18) . Zhang et al reported that tr ans-cinnamaldehyde had cy totoxic activity on human leukemia K562 cells (19) . Zhang et al., reported that apoptosis was one of the causes of cytotoxic effects of trans-cinnamaldehyde (19) . Furthermore, Lee et al., evaluated the anti-tumor effects of several cinnamaldehyde derivatives on SW620 human colon cancer cells. They stated that some cinnamaldehyde derivatives caused inhibition of AP-1 transcriptional activity in these cells ( 20) . Finally, it is proposed to investigate more closely the effects of cinnamon on cancer cells, this study was conducted on laboratory animal cancer models.
Conclusion
T he results of our study showed that C. zeylanicum aqueous extract induced apoptosis in the human myelocytic leukemia cell line. Obviously, this effect is due to the effects of the C. zeylanicum components.
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